1. Health
You can opt-out at any time. Please refer to our privacy policy for contact information.

Stage 3 Lung Cancer Prognosis

By

Updated July 14, 2014

The overall 5-year survival rate with stage 3A lung cancer is 23%, but it can vary widely. The 5-year survival rate with stage 3B lung cancer is sadly only about 10%.

What Can I Do to Help Myself?

Studies suggest that learning what you can about your cancer helps with the outcome. Ask questions. Involve your loved ones and encourage them to ask questions as well. Consider joining a support group. Learn about clinical trials that might be appropriate for your particular situation. Learning about your cancer and going through treatment can take a tremendous amount of time. Ask for and allow your loved ones and friends to help and encourage you in your journey. Don’t lose hope -– even if that hope is only to be as comfortable as possible while you enjoy the company of your loved ones.

Sources:

Edge, S. et al (Eds.). AJCC Cancer Staging Manual. 7th Edition. Springer. New York, NY. 2010.

Faithi, A. and J. Brahmer. Chemotherapy for advanced stage non-small cell lung cancer. Seminars in Thoracic and Cardiovascular Surgery. 2008. 20(3):210-6.

Jett, J. et al. Treatment of Non-small Cell Lung Cancer – Stage IIIB: ACCP Evidence-Based Clinical Guidelines (2nd Edition). Chest. 2007. 132(3 Suppl):266S-276S.

Labadede, O. et al. TNM Staging of Lung Cancer – A Quick Reference Chart. Chest. 1999. 115(1):233-235.

National Cancer Institute. Non-Small Cell Lung Cancer Treatment (PDQ). Stage IIIA Non-Small Cell Lung Cancer. 08/01/08. http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/HealthProfessional/page10.

National Cancer Institute. Non-Small Cell Lung Cancer Treatment (PDQ). Stage IIIB Non-Small Cell Lung Cancer. 08/01/08. http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/HealthProfessional/page11

Robinson, L. et al. Treatment of Non-small Cell Lung Cancer – Stage IIIA: ACCP Evidence-Based Clinical Guidelines (2nd Edition). Chest. 2007. 132(3 Suppl):243S-265S.

Santos, E. et al. Controversies in the management of stage IIIA non-small-cell lung cancer. Expert Review of Anticancer Therapy. 2008. 8(12):1913-29.

©2014 About.com. All rights reserved.

We comply with the HONcode standard
for trustworthy health
information: verify here.